UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis.

Authors:
Thompson Gana
Thompson Gana
University of Liverpool
Triantafillos Liloglou
Triantafillos Liloglou
University of Liverpool
United Kingdom
Adedamola Olayanju
Adedamola Olayanju
University of Liverpool
United Kingdom
Lawrence N Barrera
Lawrence N Barrera
University of East Anglia
United Kingdom
Robert Ferguson
Robert Ferguson
Union Memorial Hospital
United States
Fiona Campbell
Fiona Campbell
University of Liverpool
United Kingdom
Timothy Andrews
Timothy Andrews
University of York

J Pathol 2016 Feb 30;238(3):423-33. Epub 2015 Nov 30.

Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK.

The cellular defence protein Nrf2 is a mediator of oncogenesis in pancreatic ductal adenocarcinoma (PDAC) and other cancers. However, the control of Nrf2 expression and activity in cancer is not fully understood. We previously reported the absence of Keap1, a pivotal regulator of Nrf2, in ∼70% of PDAC cases. Here we describe a novel mechanism whereby the epigenetic regulator UHRF1 suppresses Keap1 protein levels. UHRF1 expression was observed in 20% (5 of 25) of benign pancreatic ducts compared to 86% (114 of 132) of pancreatic tumours, and an inverse relationship between UHRF1 and Keap1 levels in PDAC tumours (n = 124) was apparent (p = 0.002). We also provide evidence that UHRF1-mediated regulation of the Nrf2 pathway contributes to the aggressive behaviour of PDAC. Depletion of UHRF1 from PDAC cells decreased growth and enhanced apoptosis and cell cycle arrest. UHRF1 depletion also led to reduced levels of Nrf2-regulated downstream proteins and was accompanied by heightened oxidative stress, in the form of lower glutathione levels and increased reactive oxygen species. Concomitant depletion of Keap1 and UHRF1 restored Nrf2 levels and reversed cell cycle arrest and the increase in reactive oxygen species. Mechanistically, depletion of UHRF1 reduced global and tumour suppressor promoter methylation in pancreatic cancer cell lines, and KEAP1 gene promoter methylation was reduced in one of three cell lines examined. Thus, methylation of the KEAP1 gene promoter may contribute to the suppression of Keap1 protein levels by UHRF1, although our data suggest that additional mechanisms need to be explored. Finally, we demonstrate that K-Ras drives UHRF1 expression, establishing a novel link between this oncogene and Nrf2-mediated cellular protection. Since UHRF1 over-expression occurs in other cancers, its ability to regulate the Keap1-Nrf2 pathway may be critically important to the malignant behaviour of these cancers.

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.4665DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738372PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
February 2016
14 Reads

Publication Analysis

Top Keywords

uhrf1
11
levels uhrf1
8
uhrf1 expression
8
reactive oxygen
8
oxygen species
8
protein levels
8
depletion uhrf1
8
cell cycle
8
cycle arrest
8
cell lines
8
promoter methylation
8
keap1 protein
8
keap1 gene
8
gene promoter
8
keap1-nrf2 pathway
8
pancreatic cancer
8
keap1
7
levels
6
nrf2
5
pdac
5

Similar Publications